Megakaryocyte ex vivo expansion potential of three hematopoietic sources in serum and serum-free medium

P. Lefebvre, Jane Norma Winter, L. E. Kahn, J. G. Giri, I. Cohen*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Megakaryocytes (MK) were expanded from purified human CD34+ cells obtained from three sources, bone marrow (BM), mobilized peripheral blood progenitor cells (PB), and umbilical cord (UC) blood. CD34+-selected cells were cultured for 12 days with 10 ng/ml thrombopoietin (TPO), 10 ng/ml IL-3, 10 ng/ml TPO + 10 ng/ml IL-3, or 200 ng/ml promegapoietin (PMP), a chimeric dual agonist of the c-MpI and human IL-3 receptors. MK production was compared in serum-free versus human serum-supplemented liquid media. PMP and the combination of TPO and IL-3 (TPO + IL-3) increased MK production similarly. Culturing CD34+ cells with PMP in serum-free medium resulted in a twofold increase in MK yield compared with serum-supplemented medium. CD34+ cells from UC proliferated more than those from either BM or PB in liquid culture, resulting in much greater MK production under all conditions. Phenotypic analysis of the uncultured CD34+ cells showed that BM had a higher frequency of CD34+/CD41+ cells than PB or UC. TPO + IL-3 or PMP produced larger and greater numbers of BFU-MK and CFU-MK per seeded CD34+/CD41+ cell from UC than from either BM or PB. Thus, although uncultured CD34+-selected BM cells contained a higher frequency of committed mature MK progenitors, UC CD34+ cells had a greater proliferative capacity and, therefore, were more productive. PMP induced megakaryocytopoietic activity comparable to that achieved with TPO + IL-3 and may be useful for ex vivo expansion of MK for clinical trials.

Original languageEnglish (US)
Pages (from-to)199-208
Number of pages10
JournalJournal of Hematotherapy
Issue number2
StatePublished - May 27 1999

ASJC Scopus subject areas

  • Immunology
  • Hematology


Dive into the research topics of 'Megakaryocyte ex vivo expansion potential of three hematopoietic sources in serum and serum-free medium'. Together they form a unique fingerprint.

Cite this